Fingerprint
Dive into the research topics of 'Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma
Suzanne D. Conzen, Peter A. Kaufman, Christine Arvizu, Paul LeMarbre, L. Herbert Maurer, Leila A. Mott, Letha E. Mills
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations